Advertisement
active pharmaceutical ingredients
Premium
Healthcare
01 March, 2021
Steadview Capital makes partial exit from bulk drugs firm
Alternative investment firm Steadview Capital has made back-to-back partial exits from portfolio companies taking advantage of the buoyant stock market ......
Premium
Healthcare
10 February, 2021
Bulk drugs hot up as US state pension fund piles into Steadview-backed API maker
A US state pension fund has invested in a Hyderabad-based active pharmaceutical ingredients (API) maker. This is the latest in a ......
Premium
Healthcare
06 November, 2019
Why Indian bulk-drug makers are attracting greater investor interest
Private equity investors as well as pharmaceutical companies are showing higher interest in the bulk-drugs segment in India, industry executives ......
Premium
Healthcare
12 June, 2017
Symbiotec Pharmalab gets interest from new set of PE firms
Symbiotec Pharmalab Pvt. Ltd has attracted interest from a new set of global private equity investors, as majority owner Actis ......
Advertisement
Recommended for you
Advertisement